Covid-19 Treatment Market 2027 Type, Application | The Insight Partners

Covid-19 Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Treatment Type, Severity Degree); Application (Children, Adult, Special Groups, Special groups refers to pregnants and others.)

Report Code: TIPRE00010486 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

COVID-19 is an infectious disease that is caused by the most recently discovered coronavirus. COVID-19 is now a pandemic affecting many countries globally. The common symptoms of COVID-19 are fever, dry cough, and tiredness. Whereas, some patients may have aches and pains, nasal congestion, sore throat, or diarrhea. These symptoms are generally mild and begin gradually. Also, some people become infected but only have very mild symptoms.

MARKET DYNAMICS

The Covid-19 treatment market is projected to grow due to increasing cases worldwide requiring short- and long-term respiratory support and multiple partnerships for the development of treatments with clinical trials underway. However, governments all over the world are now responding to the threat of COVID-19 with all the essential measures such as social distancing, nationwide lockdown, travel restrictions, and large-scale quarantines that are anticipated to impact the businesses and consumer spending negatively. Moreover, increasing technological advancements in the pharmaceutical industry are some of the major factors expected to drive the market over the forecast period.

MARKET SCOPE

The "Covid-19 Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Covid-19 treatment market with detailed market segmentation by type, and application. The Covid-19 treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Covid-19 treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Covid-19 treatment market is segmented on the basis of type and application. On the basis of type the market is categorized as treatment type and the severity type. On the basis of treatment type the market is categorized as respiratory support, circulatory support, convalescent plasma therapy, antiviral medicine (a-interferon, lopinavir/ritonavir, ribavirin), antimicrobial therapy, renal failure and renal replacement therapy, lung replacement therapy, immunotherapy and other therapeutic measures. On the basis of severity degree, the market is categorized as light, ordinary, heavy, critical and convalescence. On the basis of application, the market is categorized as children, adult, special groups and special groups refers to pregnant and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Covid-19 treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Covid-19 treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Covid-19 treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Covid-19 treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Covid-19 treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Covid-19 treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Covid-19 treatment in the global market. Below mentioned is the list of few companies engaged in the Covid-19 treatment market.

The report also includes the profiles of key players in Covid-19 treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Applied DNA Sciences, Inc
  •   Codagenix
  •   Evvivax
  •   Generex Biotechnology Corporation
  •   GeoVax Labs, Inc.
  •   MIGAL Galilee Research Institute
  •   Moderna Therapeutics
  •   Novavax
  •   Takis Biotech
  •   Zydus Cadila


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Covid-19 Treatment Market - By Type
1.3.2 Covid-19 Treatment Market - By Application
1.3.3 Covid-19 Treatment Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. COVID-19 TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. COVID-19 TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COVID-19 TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. COVID-19 TREATMENT - GLOBAL MARKET OVERVIEW
6.2. COVID-19 TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. COVID-19 TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TREATMENT TYPE
7.3.1. Overview
7.3.2. Treatment Type Market Forecast and Analysis
7.3.3. Respiratory Support Market
7.3.3.1. Overview
7.3.3.2. Respiratory Support Market Forecast and Analysis
7.3.4. Circulatory Support Market
7.3.4.1. Overview
7.3.4.2. Circulatory Support Market Forecast and Analysis
7.3.5. Convalescent Plasma Therapy Market
7.3.5.1. Overview
7.3.5.2. Convalescent Plasma Therapy Market Forecast and Analysis
7.3.6. Antiviral Medicine (a-interferon Market
7.3.6.1. Overview
7.3.6.2. Antiviral Medicine (a-interferon Market Forecast and Analysis
7.3.7. lopinavir/ritonavir Market
7.3.7.1. Overview
7.3.7.2. lopinavir/ritonavir Market Forecast and Analysis
7.3.8. ribavirin) Market
7.3.8.1. Overview
7.3.8.2. ribavirin) Market Forecast and Analysis
7.3.9. Antimicrobial Therapy Market
7.3.9.1. Overview
7.3.9.2. Antimicrobial Therapy Market Forecast and Analysis
7.3.10. Renal Failure and Renal Replacement Therapy Market
7.3.10.1. Overview
7.3.10.2. Renal Failure and Renal Replacement Therapy Market Forecast and Analysis
7.3.11. Lung Replacement Therapy Market
7.3.11.1. Overview
7.3.11.2. Lung Replacement Therapy Market Forecast and Analysis
7.3.12. Immunotherapy Market
7.3.12.1. Overview
7.3.12.2. Immunotherapy Market Forecast and Analysis
7.3.13. Other therapeutic measures Market
7.3.13.1. Overview
7.3.13.2. Other therapeutic measures Market Forecast and Analysis
7.4. SEVERITY DEGREE
7.4.1. Overview
7.4.2. Severity Degree Market Forecast and Analysis
7.4.3. Light Market
7.4.3.1. Overview
7.4.3.2. Light Market Forecast and Analysis
7.4.4. Ordinary Market
7.4.4.1. Overview
7.4.4.2. Ordinary Market Forecast and Analysis
7.4.5. Heavy Market
7.4.5.1. Overview
7.4.5.2. Heavy Market Forecast and Analysis
7.4.6. Critical Market
7.4.6.1. Overview
7.4.6.2. Critical Market Forecast and Analysis
7.4.7. Convalescence Market
7.4.7.1. Overview
7.4.7.2. Convalescence Market Forecast and Analysis
8. COVID-19 TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CHILDREN
8.3.1. Overview
8.3.2. Children Market Forecast and Analysis
8.4. ADULT
8.4.1. Overview
8.4.2. Adult Market Forecast and Analysis
8.5. SPECIAL GROUPS
8.5.1. Overview
8.5.2. Special Groups Market Forecast and Analysis
8.6. SPECIAL GROUPS REFERS TO PREGNANTS AND OTHERS.
8.6.1. Overview
8.6.2. Special groups refers to pregnants and others. Market Forecast and Analysis
9. COVID-19 TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Covid-19 Treatment Market Overview
9.1.2 North America Covid-19 Treatment Market Forecasts and Analysis
9.1.3 North America Covid-19 Treatment Market Forecasts and Analysis - By Type
9.1.4 North America Covid-19 Treatment Market Forecasts and Analysis - By Application
9.1.5 North America Covid-19 Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Covid-19 Treatment Market
9.1.5.1.1 United States Covid-19 Treatment Market by Type
9.1.5.1.2 United States Covid-19 Treatment Market by Application
9.1.5.2 Canada Covid-19 Treatment Market
9.1.5.2.1 Canada Covid-19 Treatment Market by Type
9.1.5.2.2 Canada Covid-19 Treatment Market by Application
9.1.5.3 Mexico Covid-19 Treatment Market
9.1.5.3.1 Mexico Covid-19 Treatment Market by Type
9.1.5.3.2 Mexico Covid-19 Treatment Market by Application
9.2. EUROPE
9.2.1 Europe Covid-19 Treatment Market Overview
9.2.2 Europe Covid-19 Treatment Market Forecasts and Analysis
9.2.3 Europe Covid-19 Treatment Market Forecasts and Analysis - By Type
9.2.4 Europe Covid-19 Treatment Market Forecasts and Analysis - By Application
9.2.5 Europe Covid-19 Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Covid-19 Treatment Market
9.2.5.1.1 Germany Covid-19 Treatment Market by Type
9.2.5.1.2 Germany Covid-19 Treatment Market by Application
9.2.5.2 France Covid-19 Treatment Market
9.2.5.2.1 France Covid-19 Treatment Market by Type
9.2.5.2.2 France Covid-19 Treatment Market by Application
9.2.5.3 Italy Covid-19 Treatment Market
9.2.5.3.1 Italy Covid-19 Treatment Market by Type
9.2.5.3.2 Italy Covid-19 Treatment Market by Application
9.2.5.4 Spain Covid-19 Treatment Market
9.2.5.4.1 Spain Covid-19 Treatment Market by Type
9.2.5.4.2 Spain Covid-19 Treatment Market by Application
9.2.5.5 United Kingdom Covid-19 Treatment Market
9.2.5.5.1 United Kingdom Covid-19 Treatment Market by Type
9.2.5.5.2 United Kingdom Covid-19 Treatment Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Covid-19 Treatment Market Overview
9.3.2 Asia-Pacific Covid-19 Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Covid-19 Treatment Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Covid-19 Treatment Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Covid-19 Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Covid-19 Treatment Market
9.3.5.1.1 Australia Covid-19 Treatment Market by Type
9.3.5.1.2 Australia Covid-19 Treatment Market by Application
9.3.5.2 China Covid-19 Treatment Market
9.3.5.2.1 China Covid-19 Treatment Market by Type
9.3.5.2.2 China Covid-19 Treatment Market by Application
9.3.5.3 India Covid-19 Treatment Market
9.3.5.3.1 India Covid-19 Treatment Market by Type
9.3.5.3.2 India Covid-19 Treatment Market by Application
9.3.5.4 Japan Covid-19 Treatment Market
9.3.5.4.1 Japan Covid-19 Treatment Market by Type
9.3.5.4.2 Japan Covid-19 Treatment Market by Application
9.3.5.5 South Korea Covid-19 Treatment Market
9.3.5.5.1 South Korea Covid-19 Treatment Market by Type
9.3.5.5.2 South Korea Covid-19 Treatment Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Covid-19 Treatment Market Overview
9.4.2 Middle East and Africa Covid-19 Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Covid-19 Treatment Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Covid-19 Treatment Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Covid-19 Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Covid-19 Treatment Market
9.4.5.1.1 South Africa Covid-19 Treatment Market by Type
9.4.5.1.2 South Africa Covid-19 Treatment Market by Application
9.4.5.2 Saudi Arabia Covid-19 Treatment Market
9.4.5.2.1 Saudi Arabia Covid-19 Treatment Market by Type
9.4.5.2.2 Saudi Arabia Covid-19 Treatment Market by Application
9.4.5.3 U.A.E Covid-19 Treatment Market
9.4.5.3.1 U.A.E Covid-19 Treatment Market by Type
9.4.5.3.2 U.A.E Covid-19 Treatment Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Covid-19 Treatment Market Overview
9.5.2 South and Central America Covid-19 Treatment Market Forecasts and Analysis
9.5.3 South and Central America Covid-19 Treatment Market Forecasts and Analysis - By Type
9.5.4 South and Central America Covid-19 Treatment Market Forecasts and Analysis - By Application
9.5.5 South and Central America Covid-19 Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Covid-19 Treatment Market
9.5.5.1.1 Brazil Covid-19 Treatment Market by Type
9.5.5.1.2 Brazil Covid-19 Treatment Market by Application
9.5.5.2 Argentina Covid-19 Treatment Market
9.5.5.2.1 Argentina Covid-19 Treatment Market by Type
9.5.5.2.2 Argentina Covid-19 Treatment Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. COVID-19 TREATMENT MARKET, KEY COMPANY PROFILES
11.1. APPLIED DNA SCIENCES, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CODAGENIX
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. EVVIVAX
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GENEREX BIOTECHNOLOGY CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GEOVAX LABS, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MIGAL GALILEE RESEARCH INSTITUTE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MODERNA THERAPEUTICS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVAVAX
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TAKIS BIOTECH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ZYDUS CADILA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Applied DNA Sciences, Inc
2. Codagenix
3. Evvivax
4. Generex Biotechnology Corporation
5. GeoVax Labs, Inc.
6. MIGAL Galilee Research Institute
7. Moderna Therapeutics
8. Novavax
9. Takis Biotech
10. Zydus Cadila
TIPRE00010486
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking